Top compounds associated with response to TMEM150A


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA clofarabine CTRPv2 pan-cancer AAC -0.12 7e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 8e-05
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA Topotecan CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.12 0.0001
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA paclitaxel CCLE pan-cancer AAC -0.17 0.0003
Download CSV